RU2018132199A - Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки - Google Patents
Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки Download PDFInfo
- Publication number
- RU2018132199A RU2018132199A RU2018132199A RU2018132199A RU2018132199A RU 2018132199 A RU2018132199 A RU 2018132199A RU 2018132199 A RU2018132199 A RU 2018132199A RU 2018132199 A RU2018132199 A RU 2018132199A RU 2018132199 A RU2018132199 A RU 2018132199A
- Authority
- RU
- Russia
- Prior art keywords
- cells
- inhibitor
- stage
- pancreas
- includes processing
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 title claims 8
- 230000004069 differentiation Effects 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 title 1
- 238000000034 method Methods 0.000 claims 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 10
- 239000003112 inhibitor Substances 0.000 claims 10
- 235000010323 ascorbic acid Nutrition 0.000 claims 6
- 229960005070 ascorbic acid Drugs 0.000 claims 5
- 239000011668 ascorbic acid Substances 0.000 claims 5
- 210000000496 pancreas Anatomy 0.000 claims 5
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims 4
- 210000000936 intestine Anatomy 0.000 claims 4
- 229930002330 retinoic acid Natural products 0.000 claims 4
- 229960001727 tretinoin Drugs 0.000 claims 4
- FOORCIAZMIWALX-ULJHMMPZSA-N (z)-n-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenylpyrazol-4-yl)methanimine Chemical compound CC1=NN(C=2C=CC=CC=2)C(C)=C1\C=N/N(CC1)CCN1CC1=CC=CC=C1 FOORCIAZMIWALX-ULJHMMPZSA-N 0.000 claims 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 3
- 239000008103 glucose Substances 0.000 claims 3
- CDOVNWNANFFLFJ-UHFFFAOYSA-N 4-[6-[4-(1-piperazinyl)phenyl]-3-pyrazolo[1,5-a]pyrimidinyl]quinoline Chemical group C1CNCCN1C1=CC=C(C2=CN3N=CC(=C3N=C2)C=2C3=CC=CC=C3N=CC=2)C=C1 CDOVNWNANFFLFJ-UHFFFAOYSA-N 0.000 claims 2
- 239000012190 activator Substances 0.000 claims 2
- 210000004039 endoderm cell Anatomy 0.000 claims 2
- RYVZYACBVYKUHD-UHFFFAOYSA-N Alk5 Natural products CC#CC#CCCCCC=CC(=O)NCC(C)C RYVZYACBVYKUHD-UHFFFAOYSA-N 0.000 claims 1
- 102000001893 Bone Morphogenetic Protein Receptors Human genes 0.000 claims 1
- 108010040422 Bone Morphogenetic Protein Receptors Proteins 0.000 claims 1
- 102100028096 Homeobox protein Nkx-6.2 Human genes 0.000 claims 1
- 101000578254 Homo sapiens Homeobox protein Nkx-6.1 Proteins 0.000 claims 1
- 101000578258 Homo sapiens Homeobox protein Nkx-6.2 Proteins 0.000 claims 1
- 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 claims 1
- 150000000996 L-ascorbic acids Chemical class 0.000 claims 1
- 102100041030 Pancreas/duodenum homeobox protein 1 Human genes 0.000 claims 1
- 101710144033 Pancreas/duodenum homeobox protein 1 Proteins 0.000 claims 1
- 102100024270 Transcription factor SOX-2 Human genes 0.000 claims 1
- 210000003890 endocrine cell Anatomy 0.000 claims 1
- 210000001900 endoderm Anatomy 0.000 claims 1
- 230000009996 pancreatic endocrine effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/19—Growth and differentiation factors [GDF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Claims (18)
1. Способ получения одногормональных клеток, включающий:
(a) дифференцировку клеток поджелудочной железы передней кишки в клетки энтодермы поджелудочной железы путем обработки клеток поджелудочной железы передней кишки ингибитором shh, низкой дозой ретиноевой кислоты и аскорбиновой кислотой; и
(b) дифференцировку клеток энтодермы поджелудочной железы в одногормональные эндокринные клетки поджелудочной железы в среде, дополненной ингибитором shh, низкой дозой ретиноевой кислоты и аскорбиновой кислотой.
2. Способ по п.1, в котором клетки энтодермы поджелудочной железы экспрессируют PDX-1, более высокий уровень NKX6.1 и более низкий уровень SOX2 по сравнению с клетками поджелудочной железы передней кишки.
3. Способ по п.1, в котором стадия (а) дополнительно включает обработку активатором PKC и ингибитором рецептора BMP.
4. Способ по п.3, в котором активатор PKC представляет собой TPB.
5. Способ по п. 3 или 4, в котором ингибитор BMP представляет собой LDN-193189.
6. Способ по п.3, в котором стадия (а) включает обработку с использованием 0,25 мкМ SANT-1, 200 нМ TPB, 50 нМ ретиноевой кислоты, 200 нМ TPB, 50 нМ LDN-193189 и 0,1 мМ аскорбиновой кислоты.
7. Способ по п.1, в котором стадия (b) дополнительно включает обработку ингибитором ALK5.
8. Способ по п.7, в котором ингибитор ALK5 представляет собой ингибитор ALK5 II.
9. Способ по п.7, в котором ингибитор ALK5 представляет собой SD208.
10. Способ по п.7, в котором стадия (b) включает обработку с использованием 0,1 мМ аскорбиновой кислоты, 50 нМ ретиноевой кислоты, 0,25 мкМ SANT-1 и 1 мкМ ингибитора Alk5.
11. Способ по любому из пп. 1, 3 или 7, где ингибитор shh на стадии (a), (b) или (a) и (b) представляет собой SANT-1.
12. Способ по любому из пп. 1, 3 или 7, где способ на стадии (a), (b) или (a) и (b) включает обработку с использованием от 0,01 мМ до 1 мМ аскорбиновой кислоты.
13. Способ по любому из пп.1, 3 или 7, где способ на стадии (a), (b) или (a) и (b) включает обработку с использованием от 0,1 мМ до 0,5 мМ аскорбиновой кислоты.
14. Способ по любому из пп.1, 3 или 7, где способ на стадии (a), (b) или (a) и (b) включает обработку в среде, содержащей менее 25 мМ глюкозы.
15. Способ по п.14, в котором концентрация глюкозы находится в диапазоне от 8 мМ до 20 мМ глюкозы.
16. Способ по п.1, в котором клетки поджелудочной железы передней кишки представляют собой клетки поджелудочной железы передней кишки человека.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161579351P | 2011-12-22 | 2011-12-22 | |
| US61/579,351 | 2011-12-22 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014130042A Division RU2668798C2 (ru) | 2011-12-22 | 2012-12-07 | Способы in vitro пошаговой дифференцировки полюрипотентных клеток |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2018132199A true RU2018132199A (ru) | 2018-10-31 |
| RU2018132199A3 RU2018132199A3 (ru) | 2019-05-24 |
| RU2705001C2 RU2705001C2 (ru) | 2019-11-01 |
Family
ID=48669355
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014130042A RU2668798C2 (ru) | 2011-12-22 | 2012-12-07 | Способы in vitro пошаговой дифференцировки полюрипотентных клеток |
| RU2018132199A RU2705001C2 (ru) | 2011-12-22 | 2012-12-07 | Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014130042A RU2668798C2 (ru) | 2011-12-22 | 2012-12-07 | Способы in vitro пошаговой дифференцировки полюрипотентных клеток |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US9388386B2 (ru) |
| EP (1) | EP2794857A4 (ru) |
| JP (4) | JP6441080B2 (ru) |
| KR (2) | KR102090751B1 (ru) |
| CN (1) | CN105143446B (ru) |
| AR (1) | AR089426A1 (ru) |
| AU (3) | AU2012355698B2 (ru) |
| BR (1) | BR112014015417A8 (ru) |
| CA (1) | CA2860107C (ru) |
| HK (1) | HK1203552A1 (ru) |
| MX (1) | MX2014007744A (ru) |
| PH (1) | PH12014501429A1 (ru) |
| RU (2) | RU2668798C2 (ru) |
| SG (2) | SG11201403473QA (ru) |
| WO (1) | WO2013095953A1 (ru) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9080145B2 (en) | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
| WO2009018453A1 (en) | 2007-07-31 | 2009-02-05 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| US9062290B2 (en) | 2007-11-27 | 2015-06-23 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| CA2715878C (en) | 2008-02-21 | 2017-06-13 | Centocor Ortho Biotech Inc. | Methods, surface modified plates and compositions for cell attachment, cultivation and detachment |
| PL2310492T3 (pl) | 2008-06-30 | 2015-12-31 | Janssen Biotech Inc | Różnocowanie pluripotencjalnych komórek macierzystych |
| EP2350265B1 (en) * | 2008-10-31 | 2019-04-17 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
| WO2010051223A1 (en) | 2008-10-31 | 2010-05-06 | Centocor Ortho Biotech Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
| WO2010059775A1 (en) | 2008-11-20 | 2010-05-27 | Centocor Ortho Biotech Inc. | Pluripotent stem cell culture on micro-carriers |
| CN102257132B (zh) | 2008-11-20 | 2014-09-03 | 森托科尔奥索生物科技公司 | 用于在平面基底上进行细胞附着和培养的方法和组合物 |
| RU2579278C2 (ru) | 2009-07-20 | 2016-04-10 | Янссен Байотек, Инк. | Популяция панкреатических эндокринных клеток-предшественников для снижения концентрации глюкозы в крови и способ дифференцировки панкреатических эндодермальных клеток |
| JP6392496B2 (ja) | 2009-12-23 | 2018-09-19 | ヤンセン バイオテツク，インコーポレーテツド | ヒト胚性幹細胞の分化 |
| SG183535A1 (en) | 2010-03-01 | 2012-10-30 | Janssen Biotech Inc | Methods for purifying cells derived from pluripotent stem cells |
| CN107338217B (zh) | 2010-05-12 | 2021-02-09 | 詹森生物科技公司 | 人胚胎干细胞的分化 |
| JP6168991B2 (ja) | 2010-08-31 | 2017-07-26 | ヤンセン バイオテツク，インコーポレーテツド | ヒト胚性幹細胞の分化 |
| MX355077B (es) | 2010-08-31 | 2018-04-03 | Janssen Biotech Inc | Diferenciacion de celulas madre embrionarias humanas. |
| SG11201403473QA (en) | 2011-12-22 | 2014-10-30 | Janssen Biotech Inc | Differentiation of human embryonic stem cells into single hormonal insulin positive cells |
| AU2013230020B2 (en) | 2012-03-07 | 2018-08-09 | Janssen Biotech, Inc. | Defined media for expansion and maintenance of pluripotent stem cells |
| CA2875786C (en) | 2012-06-08 | 2022-12-06 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into pancreatic endocrine cells |
| KR20150103203A (ko) | 2012-12-31 | 2015-09-09 | 얀센 바이오테크 인코포레이티드 | 췌장 내분비 세포 내로의 분화를 위한 인간 만능 세포의 현탁 및 클러스터링 |
| US10370644B2 (en) * | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
| DK2938724T3 (da) | 2012-12-31 | 2020-12-14 | Janssen Biotech Inc | Dyrkning af humane embryonale stamceller ved luft-væskegrænsefladen til differentiering til endokrine pankreasceller |
| US10138465B2 (en) | 2012-12-31 | 2018-11-27 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into pancreatic endocrine cells using HB9 regulators |
| US8859286B2 (en) | 2013-03-14 | 2014-10-14 | Viacyte, Inc. | In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells |
| SG10201710218RA (en) | 2013-06-11 | 2018-01-30 | Harvard College | Sc-beta cells and compositions and methods for generating the same |
| WO2015048348A2 (en) | 2013-09-25 | 2015-04-02 | Pronutria, Inc. | Compositions and formulations for increasing renal function and treatment and prevention of renal diseases, and methods of production and use thereof |
| KR20160079072A (ko) * | 2013-11-01 | 2016-07-05 | 얀센 바이오테크 인코포레이티드 | 췌장 내분비 세포로의 분화를 위한 인간 만능 줄기세포의 현탁 및 클러스터링 |
| JP6588969B2 (ja) * | 2014-05-16 | 2019-10-09 | ヤンセン バイオテツク，インコーポレーテツド | 膵内分泌細胞内のｍａｆａ発現を強化するための小分子の使用 |
| WO2015178397A1 (ja) | 2014-05-20 | 2015-11-26 | 国立大学法人熊本大学 | インスリン産生細胞の分化誘導方法 |
| WO2015178431A1 (ja) * | 2014-05-21 | 2015-11-26 | 国立大学法人京都大学 | 膵芽細胞の製造方法および膵芽細胞を含む膵疾患治療剤 |
| US20170304369A1 (en) * | 2014-10-08 | 2017-10-26 | Agency For Science, Technology And Research | Methods of differentiating stem cells into liver cell lineages |
| WO2016100930A1 (en) * | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Methods for generating stem cell-derived b cells and methods of use thereof |
| WO2016100898A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Serum-free in vitro directed differentiation protocol for generating stem cell-derived b cells and uses thereof |
| WO2016100921A1 (en) * | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | METHODS FOR GENERATING STEM CELL-DERIVED β CELLS AND USES THEREOF |
| EP4374863A3 (en) | 2014-12-18 | 2024-09-04 | President and Fellows of Harvard College | Methods for generating stem cell-derived beta cells and uses thereof |
| KR102281752B1 (ko) * | 2014-12-19 | 2021-07-23 | 얀센 바이오테크 인코포레이티드 | 만능성 줄기 세포의 현탁 배양 |
| MA45479A (fr) | 2016-04-14 | 2019-02-20 | Janssen Biotech Inc | Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen |
| MA45502A (fr) * | 2016-06-21 | 2019-04-24 | Janssen Biotech Inc | Génération de cellules bêta fonctionnelles dérivées de cellules souches pluripotentes humaines ayant une respiration mitochondriale glucose-dépendante et une réponse en sécrétion d'insuline en deux phases |
| WO2019099725A1 (en) * | 2017-11-15 | 2019-05-23 | Semma Therapeutics, Inc. | Islet cell manufacturing compositions and methods of use |
| US20210214690A1 (en) * | 2018-05-07 | 2021-07-15 | President And Fellows Of Harvard College | Stem cell-derived alpha cells and methods of generating same |
| AU2019320072A1 (en) | 2018-08-10 | 2021-02-25 | Vertex Pharmaceuticals Incorporated | Stem cell derived islet differentiation |
| US20200080107A1 (en) | 2018-09-07 | 2020-03-12 | Crispr Therapeutics Ag | Universal donor cells |
| IL281531B1 (en) * | 2018-09-19 | 2024-11-01 | Takeda Pharmaceutical Company Ltd | Cells produce insulin |
| CN109749986B (zh) * | 2019-03-13 | 2021-04-02 | 武汉大学 | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 |
| JP2020146313A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146318A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146312A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146303A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146306A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146314A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146302A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146297A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146308A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146299A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146304A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146309A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146317A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146310A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146307A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146300A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146305A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146301A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146298A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146311A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| JP2020146315A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社三洋物産 | 遊技機 |
| CN114401752B (zh) | 2019-05-31 | 2023-04-04 | W.L.戈尔及同仁股份有限公司 | 具有受控氧扩散距离的细胞封装装置 |
| JP2022535239A (ja) | 2019-05-31 | 2022-08-05 | ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド | 生体適合性メンブレン複合体 |
| JP7555975B2 (ja) | 2019-05-31 | 2024-09-25 | ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド | 生体適合性メンブレン複合体 |
| JP2022534545A (ja) | 2019-05-31 | 2022-08-01 | ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド | 生体適合性メンブレン複合体 |
| BR112022004026A2 (pt) | 2019-09-05 | 2022-08-16 | Crispr Therapeutics Ag | Células doadoras universais |
| WO2021044377A1 (en) | 2019-09-05 | 2021-03-11 | Crispr Therapeutics Ag | Universal donor cells |
| AU2020371382A1 (en) * | 2019-10-21 | 2022-04-14 | Orizuru Therapeutics, Inc. | Proliferation inhibitor |
| EP4189067A4 (en) | 2020-07-31 | 2024-10-23 | Vertex Pharma | DIFFERENTIATION OF ENDOCRINE PANCREAS CELLS |
| CN112251396B (zh) * | 2020-10-09 | 2022-08-16 | 北京呈诺医学科技有限公司 | 培养基及其应用与诱导性多能干细胞向胰岛分化的方法 |
| EP4271795A1 (en) | 2020-12-31 | 2023-11-08 | CRISPR Therapeutics AG | Universal donor cells |
| CN113234664B (zh) * | 2021-05-11 | 2024-05-10 | 澳门大学 | 一种胰腺祖细胞的制备方法及其应用 |
| CA3232971A1 (en) | 2021-11-01 | 2023-05-04 | George Harb | Stem cell derived pancreatic islet differentiation |
| WO2023201361A1 (en) | 2022-04-15 | 2023-10-19 | Aspen Neuroscience, Inc. | Methods of classifying the differentiation state of cells and related compositions of differentiated cells |
| CN114836369B (zh) * | 2022-05-20 | 2023-01-17 | 呈诺再生医学科技(北京)有限公司 | 一种诱导性多能干细胞向胰岛分化的方法及其在治疗i型糖尿病中的应用 |
| WO2024151541A1 (en) | 2023-01-09 | 2024-07-18 | Sana Biotechnology, Inc. | Type-1 diabetes autoimmune mouse |
Family Cites Families (280)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3209652A (en) | 1961-03-30 | 1965-10-05 | Burgsmueller Karl | Thread whirling method |
| AT326803B (de) | 1968-08-26 | 1975-12-29 | Binder Fa G | Maschenware sowie verfahren zur herstellung derselben |
| US3935067A (en) | 1974-11-22 | 1976-01-27 | Wyo-Ben Products, Inc. | Inorganic support for culture media |
| CA1201400A (en) | 1982-04-16 | 1986-03-04 | Joel L. Williams | Chemically specific surfaces for influencing cell activity during culture |
| US4499802A (en) | 1982-09-29 | 1985-02-19 | Container Graphics Corporation | Rotary cutting die with scrap ejection |
| US4537773A (en) | 1983-12-05 | 1985-08-27 | E. I. Du Pont De Nemours And Company | α-Aminoboronic acid derivatives |
| US4557264A (en) | 1984-04-09 | 1985-12-10 | Ethicon Inc. | Surgical filament from polypropylene blended with polyethylene |
| US5089396A (en) | 1985-10-03 | 1992-02-18 | Genentech, Inc. | Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| US5215893A (en) | 1985-10-03 | 1993-06-01 | Genentech, Inc. | Nucleic acid encoding the ba chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| US4737578A (en) | 1986-02-10 | 1988-04-12 | The Salk Institute For Biological Studies | Human inhibin |
| US5863531A (en) | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
| US5804178A (en) | 1986-11-20 | 1998-09-08 | Massachusetts Institute Of Technology | Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue |
| US5567612A (en) | 1986-11-20 | 1996-10-22 | Massachusetts Institute Of Technology | Genitourinary cell-matrix structure for implantation into a human and a method of making |
| CA1340581C (en) | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
| NZ229354A (en) | 1988-07-01 | 1990-09-26 | Becton Dickinson Co | Treating polymer surfaces with a gas plasma and then applying a layer of endothelial cells to the surface |
| EP0363125A3 (en) | 1988-10-03 | 1990-08-16 | Hana Biologics Inc. | Proliferated pancreatic endocrine cell product and process |
| SU1767433A1 (ru) | 1989-11-27 | 1992-10-07 | Пермский государственный медицинский институт | Способ определени инсулинорезистентности имунного генеза у больных сахарным диабетом I типа |
| US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
| WO1992019759A1 (en) | 1991-04-25 | 1992-11-12 | Chugai Seiyaku Kabushiki Kaisha | Reconstituted human antibody against human interleukin 6 receptor |
| US5449383A (en) | 1992-03-18 | 1995-09-12 | Chatelier; Ronald C. | Cell growth substrates |
| GB9206861D0 (en) | 1992-03-28 | 1992-05-13 | Univ Manchester | Wound healing and treatment of fibrotic disorders |
| CA2114282A1 (en) | 1993-01-28 | 1994-07-29 | Lothar Schilder | Multi-layered implant |
| JP3525221B2 (ja) | 1993-02-17 | 2004-05-10 | 味の素株式会社 | 免疫抑制剤 |
| WO1994023572A1 (en) | 1993-04-08 | 1994-10-27 | Human Cell Cultures, Inc. | Cell culturing method and medium |
| US5523226A (en) * | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
| GB9310557D0 (en) | 1993-05-21 | 1993-07-07 | Smithkline Beecham Plc | Novel process and apparatus |
| TW257671B (ru) | 1993-11-19 | 1995-09-21 | Ciba Geigy | |
| US6001647A (en) | 1994-04-28 | 1999-12-14 | Ixion Biotechnology, Inc. | In vitro growth of functional islets of Langerhans and in vivo uses thereof |
| US5834308A (en) | 1994-04-28 | 1998-11-10 | University Of Florida Research Foundation, Inc. | In vitro growth of functional islets of Langerhans |
| US6703017B1 (en) | 1994-04-28 | 2004-03-09 | Ixion Biotechnology, Inc. | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
| US6083903A (en) | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
| CN1075387C (zh) | 1994-12-29 | 2001-11-28 | 中外制药株式会社 | 含有il－6拮抗剂的抗肿瘤剂的作用增强剂 |
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US5718922A (en) | 1995-05-31 | 1998-02-17 | Schepens Eye Research Institute, Inc. | Intravitreal microsphere drug delivery and method of preparation |
| US5908782A (en) | 1995-06-05 | 1999-06-01 | Osiris Therapeutics, Inc. | Chemically defined medium for human mesenchymal stem cells |
| US5681561A (en) | 1995-06-07 | 1997-10-28 | Life Medical Sciences, Inc. | Compositions and methods for improving autologous fat grafting |
| AU5734998A (en) | 1997-01-10 | 1998-08-03 | Life Technologies, Inc. | Embryonic stem cell serum replacement |
| PT1028954E (pt) | 1997-04-24 | 2003-11-28 | Ortho Mcneil Pharm Inc | Imidazoles substituidos uteis no tratamento de doencas inflamatorias |
| CA2294944A1 (en) | 1997-07-03 | 1999-01-14 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells from peripheral blood |
| PT1538206E (pt) | 1997-09-16 | 2010-04-12 | Centocor Ortho Biotech Inc | Método para a síntese química e construção completa de genes e genomas |
| US6670127B2 (en) | 1997-09-16 | 2003-12-30 | Egea Biosciences, Inc. | Method for assembly of a polynucleotide encoding a target polypeptide |
| EP1025204A4 (en) | 1997-10-23 | 2001-02-28 | Geron Corp | METHODS AND MATERIALS USEFUL FOR THE GROWTH OF PRIMORIAL PRIMATE STEM CELLS |
| CO4980885A1 (es) | 1997-12-29 | 2000-11-27 | Ortho Mcneil Pharm Inc | Compuestos de trifenilpropanamida utiles en el tratamiento de inflamaciones y metodos para preparar dicho compuesto |
| ATE316795T1 (de) | 1998-03-18 | 2006-02-15 | Osiris Therapeutics Inc | Mesenchymale stammzellen für die prävention und behandlung von immunantworten bei transplantationen |
| MY132496A (en) | 1998-05-11 | 2007-10-31 | Vertex Pharma | Inhibitors of p38 |
| US6413773B1 (en) | 1998-06-01 | 2002-07-02 | The Regents Of The University Of California | Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation |
| US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
| US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
| US6610540B1 (en) | 1998-11-18 | 2003-08-26 | California Institute Of Technology | Low oxygen culturing of central nervous system progenitor cells |
| US6413556B1 (en) | 1999-01-08 | 2002-07-02 | Sky High, Llc | Aqueous anti-apoptotic compositions |
| EP1144597A2 (en) | 1999-01-21 | 2001-10-17 | Vitro Diagnostics, Inc. | Immortalized cell lines and methods of making the same |
| WO2000047717A1 (en) | 1999-02-11 | 2000-08-17 | Hanmi Pharm. Co., Ltd. | Avian pluripotent embryonic germ cell line |
| US6815203B1 (en) | 1999-06-23 | 2004-11-09 | Joslin Diabetes Center, Inc. | Methods of making pancreatic islet cells |
| US6333029B1 (en) | 1999-06-30 | 2001-12-25 | Ethicon, Inc. | Porous tissue scaffoldings for the repair of regeneration of tissue |
| US6306424B1 (en) | 1999-06-30 | 2001-10-23 | Ethicon, Inc. | Foam composite for the repair or regeneration of tissue |
| CA2385628A1 (en) | 1999-09-27 | 2001-04-05 | Ammon B. Peck | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
| US6685936B2 (en) | 1999-10-12 | 2004-02-03 | Osiris Therapeutics, Inc. | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
| US20030082155A1 (en) | 1999-12-06 | 2003-05-01 | Habener Joel F. | Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| EP1240518A4 (en) | 1999-12-13 | 2006-05-17 | Scripps Research Inst | MARKERS FOR THE IDENTIFICATION AND INSULATION OF PRE-GENERIC CELLS OF A AND B PANCREAS ISOLATED CELLS |
| US7005252B1 (en) | 2000-03-09 | 2006-02-28 | Wisconsin Alumni Research Foundation | Serum free cultivation of primate embryonic stem cells |
| US7439064B2 (en) | 2000-03-09 | 2008-10-21 | Wicell Research Institute, Inc. | Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium |
| US6436704B1 (en) | 2000-04-10 | 2002-08-20 | Raven Biotechnologies, Inc. | Human pancreatic epithelial progenitor cells and methods of isolation and use thereof |
| US6458589B1 (en) | 2000-04-27 | 2002-10-01 | Geron Corporation | Hepatocyte lineage cells derived from pluripotent stem cells |
| AU2001274624A1 (en) | 2000-06-26 | 2002-01-08 | Renomedix Institute Inc. | Cell fraction containing cells capable of differentiating into nervous system cells |
| PT1333833E (pt) | 2000-10-23 | 2011-12-09 | Glaxosmithkline Llc | Novo composto 8h-pirido[2,3-d]pirimidin-7-ona trissusbtituída para o tratamento de doenças mediadas por csbp/p38 cinase |
| KR20040016828A (ko) | 2000-12-08 | 2004-02-25 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 키나제 저해제로서 인다졸릴-치환된 피롤린 화합물 |
| AU2737102A (en) | 2000-12-08 | 2002-06-18 | Ortho Mcneil Pharm Inc | Macroheterocylic compounds useful as kinase inhibitors |
| US6599323B2 (en) | 2000-12-21 | 2003-07-29 | Ethicon, Inc. | Reinforced tissue implants and methods of manufacture and use |
| WO2002059278A2 (en) | 2001-01-24 | 2002-08-01 | The Government Of The United States Of America, As Represented By The Secretary Of Department Of Health & Human Services | Differentiation of stem cells to pancreatic endocrine cells |
| DE60239384D1 (de) | 2001-01-25 | 2011-04-21 | Us Of America Represented By The Secretary Dept Of Health And Human Services | Formulierungen von borsäure-verbindungen |
| US6656488B2 (en) | 2001-04-11 | 2003-12-02 | Ethicon Endo-Surgery, Inc. | Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering |
| DE10290025T1 (de) | 2001-04-19 | 2003-10-09 | Develogen Ag | Verfahren zur Differenzierung von Stammzellen in Insulin-produzierende Zellen |
| WO2002088335A1 (fr) | 2001-04-24 | 2002-11-07 | Ajinomoto Co., Inc. | Cellules souches et procede d'extraction de ces cellules |
| WO2002092756A2 (en) | 2001-05-15 | 2002-11-21 | Rappaport Family Institute For Research In The Medical Sciences | Insulin producing cells derived from human embryonic stem cells |
| US6626950B2 (en) | 2001-06-28 | 2003-09-30 | Ethicon, Inc. | Composite scaffold with post anchor for the repair and regeneration of tissue |
| KR100418195B1 (ko) | 2001-07-05 | 2004-02-11 | 주식회사 우리기술 | 전력케이블의 다중절연진단장치 및 그 방법 |
| GB0117583D0 (en) | 2001-07-19 | 2001-09-12 | Astrazeneca Ab | Novel compounds |
| US7432104B2 (en) | 2001-08-06 | 2008-10-07 | Bresgen Inc. | Methods for the culture of human embryonic stem cells on human feeder cells |
| US6617152B2 (en) | 2001-09-04 | 2003-09-09 | Corning Inc | Method for creating a cell growth surface on a polymeric substrate |
| EP1298201A1 (en) | 2001-09-27 | 2003-04-02 | Cardion AG | Process for the production of cells exhibiting an islet-beta-cell-like state |
| EP1444345A4 (en) | 2001-10-18 | 2004-12-08 | Ixion Biotechnology Inc | TRANSFORMATION OF STEM CELLS AND LIVER PROGENITORS INTO FUNCTIONAL CELLS OF PANCREAS |
| WO2003042405A2 (en) | 2001-11-15 | 2003-05-22 | Children's Medical Center Corporation | Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| KR101083454B1 (ko) | 2001-12-07 | 2011-11-16 | 사이토리 테라퓨틱스, 인크. | 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한 시스템 및 방법 |
| JP4666567B2 (ja) | 2001-12-07 | 2011-04-06 | ジェロン・コーポレーション | ヒト胚幹細胞由来の膵島細胞 |
| AU2002218893A1 (en) | 2001-12-21 | 2003-07-09 | Thromb-X Nv | Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability |
| AU2002367091A1 (en) | 2001-12-28 | 2003-07-15 | Cellartis Ab | A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| US20030162290A1 (en) | 2002-01-25 | 2003-08-28 | Kazutomo Inoue | Method for inducing differentiation of embryonic stem cells into functioning cells |
| US20030180268A1 (en) | 2002-02-05 | 2003-09-25 | Anthony Atala | Tissue engineered construct for supplementing or replacing a damaged organ |
| US20050208029A1 (en) | 2002-04-17 | 2005-09-22 | Akihiro Umezawa | Method of forming pancreatic beta cells from mesenchymal cells |
| US20040161419A1 (en) | 2002-04-19 | 2004-08-19 | Strom Stephen C. | Placental stem cells and uses thereof |
| AU2003225295A1 (en) | 2002-05-08 | 2003-11-11 | Janssen Pharmaceutica N.V. | Substituted pyrroline kinase inhibitors |
| US20060003446A1 (en) | 2002-05-17 | 2006-01-05 | Gordon Keller | Mesoderm and definitive endoderm cell populations |
| CA2485862A1 (en) | 2002-05-28 | 2003-12-11 | Becton, Dickinson And Company | Expansion and transdifferentiation of human acinar cells |
| US6987110B2 (en) | 2002-06-05 | 2006-01-17 | Janssen Pharmaceutica N.V. | Substituted pyrrolines as kinase inhibitors |
| GB0212976D0 (en) | 2002-06-06 | 2002-07-17 | Tonejet Corp Pty Ltd | Ejection method and apparatus |
| CN1171991C (zh) | 2002-07-08 | 2004-10-20 | 徐如祥 | 人神经干细胞的培养方法 |
| US6877147B2 (en) | 2002-07-22 | 2005-04-05 | Broadcom Corporation | Technique to assess timing delay by use of layout quality analyzer comparison |
| US7838290B2 (en) | 2002-07-25 | 2010-11-23 | The Scripps Research Institute | Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| EP1539930A4 (en) | 2002-07-29 | 2006-08-09 | Es Cell Int Pte Ltd | METHOD IN MULTIPLE STAGES OF DIFFERENTIATION OF POSITIVE INSULIN-SENSITIVE CELLS, GLUCOSE |
| WO2004016747A2 (en) | 2002-08-14 | 2004-02-26 | University Of Florida | Bone marrow cell differentiation |
| US7371576B2 (en) | 2002-09-06 | 2008-05-13 | Reneuron, Inc. | CD56 positive human adult pancreatic endocrine progenitor cells |
| US9969977B2 (en) | 2002-09-20 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| US20040062753A1 (en) | 2002-09-27 | 2004-04-01 | Alireza Rezania | Composite scaffolds seeded with mammalian cells |
| WO2004044158A2 (en) | 2002-11-08 | 2004-05-27 | The Johns Hopkins University | Human embryonic stem cell cultures, and compositions and methods for growing same |
| US7144999B2 (en) | 2002-11-23 | 2006-12-05 | Isis Pharmaceuticals, Inc. | Modulation of hypoxia-inducible factor 1 alpha expression |
| WO2004050827A2 (en) | 2002-12-05 | 2004-06-17 | Technion Research & Development Foundation Ltd. | Cultured human pancreatic islets, and uses thereof |
| PT1572984E (pt) | 2002-12-16 | 2016-06-03 | Technion Res & Dev Foundation | Sistema de cultura para células estaminais embrionárias humanas sem células alimentadoras e sem xeno |
| US20050118148A1 (en) | 2002-12-20 | 2005-06-02 | Roland Stein | Compositions and methods related to mammalian Maf-A |
| BRPI0407074A (pt) | 2003-01-29 | 2006-01-24 | Takeda Pharmaceutical | Método para produção de uma preparação revestida, preparação revestida, e, método para melhorar a dissolução do cloridreto de pioglitazona de uma preparação revestida com cloridreto de pioglitazona |
| RU2359671C2 (ru) | 2003-01-29 | 2009-06-27 | Такеда Фармасьютикал Компани Лимитед | Способ получения препарата с покрытием |
| US20070155661A1 (en) | 2003-02-14 | 2007-07-05 | The Board Of Trustees Of The Leland Standord Junior University | Methods and compositions for modulating the development of stem cells |
| WO2005045001A2 (en) | 2003-02-14 | 2005-05-19 | The Board Of Trustees Of The Leland Stanford Junior University | Insulin-producing cells derived from stem cells |
| US20070020242A1 (en) | 2003-03-27 | 2007-01-25 | Ixion Biotechnology, Inc. | Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway |
| US20060194315A1 (en) | 2003-03-31 | 2006-08-31 | Condie Brian G | Compositions and methods for the control, differentiaton and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway |
| US20090203141A1 (en) | 2003-05-15 | 2009-08-13 | Shi-Lung Lin | Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents |
| US7413734B2 (en) | 2003-06-27 | 2008-08-19 | Ethicon, Incorporated | Treatment of retinitis pigmentosa with human umbilical cord cells |
| IL161903A0 (en) | 2003-07-17 | 2005-11-20 | Gamida Cell Ltd | Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs |
| ITRM20030395A1 (it) | 2003-08-12 | 2005-02-13 | Istituto Naz Per Le Malattie Infettive Lazz | Terreno di coltura per il mantenimento, la proliferazione e il differenziamento di cellule di mammifero. |
| US7569385B2 (en) | 2003-08-14 | 2009-08-04 | The Regents Of The University Of California | Multipotent amniotic fetal stem cells |
| US7157275B2 (en) | 2003-08-15 | 2007-01-02 | Becton, Dickinson And Company | Peptides for enhanced cell attachment and growth |
| EP1670900A4 (en) | 2003-08-27 | 2008-06-11 | Stemcells California Inc | ENHANCED PANCREATIC STEM CELL AND PRECURSOR CELL POPULATIONS AND METHOD OF IDENTIFYING, INSULATING AND ENRICHING SUCH POPULATIONS |
| CA2550010A1 (en) | 2003-12-17 | 2005-06-30 | Allergan, Inc. | Methods for treating retinoid responsive disorders using selective inhibitors of cyp26a and cyp26b |
| US20060030042A1 (en) | 2003-12-19 | 2006-02-09 | Ali Brivanlou | Maintenance of embryonic stem cells by the GSK-3 inhibitor 6-bromoindirubin-3'-oxime |
| GB0329498D0 (en) | 2003-12-19 | 2004-01-28 | Novartis Ag | Organic compounds |
| US7541185B2 (en) | 2003-12-23 | 2009-06-02 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
| US7625753B2 (en) | 2003-12-23 | 2009-12-01 | Cythera, Inc. | Expansion of definitive endoderm cells |
| US20050266554A1 (en) | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
| CN112813019A (zh) | 2003-12-23 | 2021-05-18 | 维亚希特公司 | 定形内胚层 |
| JP4819697B2 (ja) | 2003-12-23 | 2011-11-24 | ヴィアサイト，インコーポレイテッド | 胚体内胚葉 |
| WO2005065354A2 (en) | 2003-12-31 | 2005-07-21 | The Burnham Institute | Defined media for pluripotent stem cell culture |
| TWI334443B (en) | 2003-12-31 | 2010-12-11 | Ind Tech Res Inst | Method of single cell culture of undifferentiated human embryonic stem cells |
| US7794704B2 (en) | 2004-01-23 | 2010-09-14 | Advanced Cell Technology, Inc. | Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration |
| US20080241107A1 (en) | 2004-01-23 | 2008-10-02 | Copland Iii John A | Methods and Compositions For Preparing Pancreatic Insulin Secreting Cells |
| US20070298453A1 (en) | 2004-02-12 | 2007-12-27 | University Of Newcastle Upon Tyne | Stem Cells |
| US7964401B2 (en) | 2004-02-19 | 2011-06-21 | Kyoto University | Screening method for somatic cell nuclear reprogramming substance affecting ECAT2 and ECAT3 |
| WO2005086860A2 (en) | 2004-03-09 | 2005-09-22 | Gang Xu | Methods for generating insulin-producing cells |
| WO2005086845A2 (en) | 2004-03-10 | 2005-09-22 | Regents Of The University Of California | Compositions and methods for growth of embryonic stem cells |
| RU2375448C2 (ru) | 2004-03-23 | 2009-12-10 | Асубио Фарма Ко., Лтд. | Способ выращивания плюрипотентных стволовых клеток |
| WO2005097980A2 (en) | 2004-03-26 | 2005-10-20 | Geron Corporation | New protocols for making hepatocytes from embryonic stem cells |
| EP1730268A2 (en) | 2004-04-01 | 2006-12-13 | Wisconsin Alumni Research Foundation | Differentiation of stem cells to endoderm and pancreatic lineage |
| JP4926946B2 (ja) | 2004-04-27 | 2012-05-09 | ヴィアサイト，インコーポレイテッド | Ｐｄｘ１発現性内胚葉 |
| WO2006016999A1 (en) | 2004-07-09 | 2006-02-16 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
| MX2007001772A (es) | 2004-08-13 | 2007-07-11 | Univ Georgia Res Found | Composiciones y metodos para auto-renovacion y diferenciacion de celulas troncales embrionicas humanas. |
| WO2006026473A2 (en) | 2004-08-25 | 2006-03-09 | University Of Georgia Research Foundation, Inc. | METHODS AND COMPOSITIONS UTILIZING MYC AND GSK3ß TO MANIPULATE THE PLURIPOTENCY OF EMBRYONIC STEM CELLS |
| DE102004043256B4 (de) | 2004-09-07 | 2013-09-19 | Rheinische Friedrich-Wilhelms-Universität Bonn | Skalierbarer Prozess zur Kultivierung undifferenzierter Stammzellen in Suspension |
| CA2579643C (en) | 2004-09-08 | 2011-12-06 | Wisconsin Alumni Research Foundation | Medium and culture of embryonic stem cells |
| US7442548B2 (en) | 2004-09-08 | 2008-10-28 | Wisconsin Alumni Research Foundation | Culturing human embryonic stem cells in medium containing pipecholic acid and gamma amino butyric acid |
| CA2596231A1 (en) | 2005-01-28 | 2006-08-03 | Novathera Ltd | Methods for embryonic stem cell culture |
| CA2613812A1 (en) | 2005-01-31 | 2006-08-10 | Es Cell International Pte Ltd. | Directed differentiation of embryonic stem cells and uses thereof |
| WO2006088867A2 (en) | 2005-02-15 | 2006-08-24 | Medistem Laboratories, Incorporated | Method for expansion of stem cells |
| JP5265204B2 (ja) | 2005-03-04 | 2013-08-14 | ライフスキャン・インコーポレイテッド | 成人膵臓由来間質細胞 |
| GB0505970D0 (en) | 2005-03-23 | 2005-04-27 | Univ Edinburgh | Culture medium containing kinase inhibitor, and uses thereof |
| CN101589137B (zh) | 2005-03-31 | 2013-06-05 | 斯丹姆涅恩有限公司 | 羊膜来源的细胞组合物及其制备方法和用途 |
| CN100425694C (zh) | 2005-04-15 | 2008-10-15 | 北京大学 | 诱导胚胎干细胞向胰腺细胞分化的方法 |
| WO2006113470A2 (en) | 2005-04-15 | 2006-10-26 | Geron Corporation | Cancer treatment by combined inhibition of proteasome and telomerase activities |
| EP1874367B1 (en) | 2005-04-26 | 2011-07-06 | Arhus Universitet | Biocompatible material for surgical implants and cell guiding tissue culture surfaces |
| WO2006117925A1 (ja) * | 2005-04-26 | 2006-11-09 | Hitachi Medical Corporation | 膵臓β細胞再生方法および装置 |
| WO2006126574A1 (ja) | 2005-05-24 | 2006-11-30 | Kumamoto University | Es細胞の分化誘導方法 |
| AU2006202209B2 (en) | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
| WO2006135824A1 (en) | 2005-06-10 | 2006-12-21 | Irm Llc | Compounds that maintain pluripotency of embryonic stem cells |
| WO2006138433A2 (en) | 2005-06-14 | 2006-12-28 | The Regents Of The University Of California | Induction of cell differentiation by class i bhlh polypeptides |
| EP1931764A1 (en) | 2005-06-21 | 2008-06-18 | GE Healthcare Bio-Sciences AB | Method for cell culture |
| US9074181B2 (en) | 2005-06-22 | 2015-07-07 | Asterias Biotherapeutics, Inc. | Suspension culture of human embryonic stem cells |
| ATE439349T1 (de) | 2005-06-30 | 2009-08-15 | Janssen Pharmaceutica Nv | Cyclische anilinopyridinotriazine als gsk-3- inhibitoren |
| CA2616863A1 (en) | 2005-07-29 | 2007-02-01 | Australian Stem Cell Centre Limited | Compositions and methods for growth of pluripotent cells |
| WO2007016485A2 (en) | 2005-07-29 | 2007-02-08 | Athersys, Inc. | Use of a gsk-3 inhibitor to maintain potency of cultured cells |
| WO2007025234A2 (en) | 2005-08-26 | 2007-03-01 | The Trustees Of Columbia University In The City Of New York | Generation of pancreatic endocrine cells from primary duct cell cultures and methods of use for treatment of diabetes |
| SG177946A1 (en) | 2005-08-29 | 2012-02-28 | Technion Res & Dev Foundation | Media for culturing stem cells |
| AU2006285468A1 (en) | 2005-09-02 | 2007-03-08 | Agency For Science, Technology And Research | Method of deriving progenitor cell line |
| GB2444686B (en) | 2005-09-12 | 2010-08-25 | Es Cell Int Pte Ltd | Differentiation of pluripotent stem cells using p38 MAPK inhibitors or prostaglandins |
| JP5131833B2 (ja) | 2005-10-05 | 2013-01-30 | 晃文 松山 | 脂肪組織由来細胞から膵内分泌細胞を得る方法 |
| CN101310012B (zh) | 2005-10-14 | 2012-05-09 | 明尼苏达大学董事会 | 非胚胎干细胞分化成具有胰腺表型的细胞 |
| US7732202B2 (en) | 2005-10-21 | 2010-06-08 | International Stem Cell Corporation | Oxygen tension for the parthenogenic activation of human oocytes for the production of human embryonic stem cells |
| US20070122905A1 (en) | 2005-10-27 | 2007-05-31 | D Amour Kevin A | PDX1-expressing dorsal and ventral foregut endoderm |
| ES2367525T3 (es) | 2005-12-13 | 2011-11-04 | Kyoto University | Factor de reprogramación celular. |
| WO2007082963A1 (es) | 2006-01-18 | 2007-07-26 | Fundación Instituto Valenciano De Infertilidad | Líneas de células madre embrionarias humanas y métodos para usar las mismas |
| CN113088483A (zh) | 2006-02-23 | 2021-07-09 | 维亚赛特公司 | 用于培养可分化细胞的组合物和方法 |
| EP2650359B1 (en) | 2006-03-02 | 2022-05-04 | Viacyte, Inc. | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
| US7695965B2 (en) | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
| AU2007244675A1 (en) | 2006-04-28 | 2007-11-08 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| US8741643B2 (en) | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
| WO2007130474A2 (en) | 2006-05-02 | 2007-11-15 | Wisconsin Alumni Research Foundation | Method of differentiating stem cells into cells of the endoderm and pancreatic lineage |
| US8685730B2 (en) | 2006-05-02 | 2014-04-01 | Wisconsin Alumni Research Foundation | Methods and devices for differentiating pluripotent stem cells into cells of the pancreatic lineage |
| WO2007136673A2 (en) | 2006-05-19 | 2007-11-29 | Medistem Laboratories, Inc. | Treatment of disc degenerative disease and compositions for same |
| US7964402B2 (en) | 2006-05-25 | 2011-06-21 | Sanford-Burnham Medical Research Institute | Methods for culture and production of single cell populations of human embryonic stem cells |
| CN101541953A (zh) | 2006-06-02 | 2009-09-23 | 佐治亚大学研究基金会 | 通过从人胚胎干细胞获得的定形内胚层细胞的分化得到胰和肝内胚层细胞及组织 |
| AU2007254766A1 (en) | 2006-06-02 | 2007-12-13 | University Of Georgia Research Foundation, Inc. | Pancreatic and liver endoderm cells and tissue by differentiation of definitive endoderm cells obtained from human embryonic stems |
| WO2007149182A2 (en) | 2006-06-19 | 2007-12-27 | Geron Corporation | Differentiation and enrichment of islet-like cells from human pluripotent stem cells |
| CN100494359C (zh) | 2006-06-23 | 2009-06-03 | 中日友好医院 | 神经干细胞三维立体培养体外扩增的方法 |
| EP2046946B8 (en) | 2006-06-26 | 2017-01-25 | Lifescan, Inc. | Pluripotent stem cell culture |
| US20080003676A1 (en) | 2006-06-26 | 2008-01-03 | Millipore Corporation | Growth of embryonic stem cells |
| AU2007270069B2 (en) | 2006-07-06 | 2013-05-16 | Es Cell International Pte Ltd | Method for stem cell culture and cells derived therefrom |
| WO2008013664A2 (en) | 2006-07-26 | 2008-01-31 | Cythera, Inc. | Methods of producing pancreatic hormones |
| DK3441459T3 (da) | 2006-08-02 | 2021-06-07 | Technion Res & Dev Foundation | Fremgangsmåder til ekspansion af embryonale stamceller i en suspensionskultur |
| KR101331510B1 (ko) | 2006-08-30 | 2013-11-20 | 재단법인서울대학교산학협력재단 | 저농도의 포도당을 함유하는 인간 배아줄기세포용 배지조성물 및 이를 이용한 인간 배아 줄기세포로부터 인슐린생산 세포 또는 세포괴로 분화시키는 방법, 그리고그로부터 유도된 인슐린 생산 세포 또는 세포괴 |
| JP2008099662A (ja) | 2006-09-22 | 2008-05-01 | Institute Of Physical & Chemical Research | 幹細胞の培養方法 |
| US20080091234A1 (en) | 2006-09-26 | 2008-04-17 | Kladakis Stephanie M | Method for modifying a medical implant surface for promoting tissue growth |
| WO2008048647A1 (en) | 2006-10-17 | 2008-04-24 | Cythera, Inc. | Modulation of the phosphatidylinositol-3-kinase pathway in the differentiation of human embryonic stem cells |
| CN101611016B (zh) | 2006-10-17 | 2012-01-25 | 斯蒂菲尔实验室公司 | 他拉罗唑代谢物 |
| US8835163B2 (en) | 2006-10-18 | 2014-09-16 | The Board Of Trustees Of The University Of Illinois | Embryonic-like stem cells derived from adult human peripheral blood and methods of use |
| JP5067949B2 (ja) | 2006-11-09 | 2012-11-07 | 独立行政法人国立国際医療研究センター | 霊長類動物胚性幹細胞の培養及び継代方法、並びにその分化誘導方法 |
| US8217027B2 (en) | 2006-12-21 | 2012-07-10 | Abbott Laboratories | Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| WO2008086005A1 (en) | 2007-01-09 | 2008-07-17 | University Of South Florida | Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof |
| CN103627671A (zh) | 2007-01-30 | 2014-03-12 | 佐治亚大学研究基金会 | 产生中内胚层细胞及多能游走细胞的方法与细胞群及用途 |
| GB0703188D0 (en) | 2007-02-19 | 2007-03-28 | Roger Land Building | Large scale production of stem cells |
| WO2008148105A1 (en) | 2007-05-25 | 2008-12-04 | Medistem Laboratories, Inc. | Endometrial stem cells and methods of making and using same |
| WO2009006422A1 (en) | 2007-06-29 | 2009-01-08 | Stem Cell Products, Inc. | Automated method and apparatus for embryonic stem cell culture |
| MX2010000348A (es) | 2007-07-01 | 2010-04-12 | Lifescan Inc | Cultivo de celulas madre pluripotentes individuales. |
| BRPI0814425A2 (pt) | 2007-07-18 | 2014-10-21 | Lifescan Inc | Diferenciação de células-tronco embrionárias humanas |
| RU2010107181A (ru) | 2007-07-31 | 2011-09-20 | Лайфскен, Инк. (Us) | Дифференцировка плюрипотентных стволовых клеток с использованием питающих клеток человека |
| WO2009018453A1 (en) * | 2007-07-31 | 2009-02-05 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| MX2010002179A (es) | 2007-08-24 | 2010-04-27 | Stichting Het Nl Kanker I | Composicion para el tratamiento de enfermedades neoplasicas. |
| WO2009061442A1 (en) | 2007-11-06 | 2009-05-14 | Children's Medical Center Corporation | Method to produce induced pluripotent stem (ips) cells form non-embryonic human cells |
| US9062290B2 (en) | 2007-11-27 | 2015-06-23 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| SG154367A1 (en) | 2008-01-31 | 2009-08-28 | Es Cell Int Pte Ltd | Method of differentiating stem cells |
| WO2009096049A1 (ja) | 2008-02-01 | 2009-08-06 | Kyoto University | 人工多能性幹細胞由来分化細胞 |
| WO2009101407A2 (en) | 2008-02-11 | 2009-08-20 | Cambridge Enterprise Limited | Improved reprogramming of mammalian cells, and the cells obtained |
| CA2715878C (en) | 2008-02-21 | 2017-06-13 | Centocor Ortho Biotech Inc. | Methods, surface modified plates and compositions for cell attachment, cultivation and detachment |
| WO2009110215A1 (ja) | 2008-03-03 | 2009-09-11 | 独立行政法人 科学技術振興機構 | 繊毛細胞の分化誘導方法 |
| WO2009116951A2 (en) | 2008-03-17 | 2009-09-24 | Agency For Science, Technology And Research | Microcarriers for stem cell culture |
| RU2359030C1 (ru) | 2008-03-19 | 2009-06-20 | Общество С Ограниченной Ответственностью "Лаборатория Клеточных Технологий" | Способ получения эндотелиальных клеток из эмбриональных стволовых клеток человека (варианты) |
| AU2008355123B2 (en) | 2008-04-21 | 2014-12-04 | Viacyte, Inc. | Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells |
| US8338170B2 (en) * | 2008-04-21 | 2012-12-25 | Viacyte, Inc. | Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells |
| WO2009132083A2 (en) | 2008-04-22 | 2009-10-29 | President And Fellows Of Harvard College | Compositions and methods for promoting the generation of pdx1+ pancreatic cells |
| US7939322B2 (en) | 2008-04-24 | 2011-05-10 | Centocor Ortho Biotech Inc. | Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm |
| US8623648B2 (en) | 2008-04-24 | 2014-01-07 | Janssen Biotech, Inc. | Treatment of pluripotent cells |
| EP2294187A2 (en) | 2008-05-21 | 2011-03-16 | BioE LLC | Differentiation of multi-lineage progenitor cells to pancreatic cells |
| US20090298178A1 (en) | 2008-06-03 | 2009-12-03 | D Amour Kevin Allen | Growth factors for production of definitive endoderm |
| WO2009154606A1 (en) | 2008-06-03 | 2009-12-23 | Cythera, Inc. | Growth factors for production of definitive endoderm |
| PL2310492T3 (pl) | 2008-06-30 | 2015-12-31 | Janssen Biotech Inc | Różnocowanie pluripotencjalnych komórek macierzystych |
| DE102008032236A1 (de) | 2008-06-30 | 2010-04-01 | Eberhard-Karls-Universität Tübingen | Isolierung und/oder Identifizierung von Stammzellen mit adipozytärem, chondrozytärem und pankreatischem Differenzierungspotential |
| US20100028307A1 (en) | 2008-07-31 | 2010-02-04 | O'neil John J | Pluripotent stem cell differentiation |
| WO2010022395A2 (en) | 2008-08-22 | 2010-02-25 | President And Fellows Of Harvard College | Methods of reprogramming cells |
| EP2334804B1 (en) | 2008-10-07 | 2013-12-04 | True North Therapeutics, Inc. | Co-culture compositions and methods |
| EP2350265B1 (en) * | 2008-10-31 | 2019-04-17 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
| WO2010051223A1 (en) * | 2008-10-31 | 2010-05-06 | Centocor Ortho Biotech Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
| US8008075B2 (en) | 2008-11-04 | 2011-08-30 | Viacyte, Inc. | Stem cell aggregate suspension compositions and methods of differentiation thereof |
| WO2010053472A1 (en) | 2008-11-04 | 2010-05-14 | Novocell, Inc. | Stem cell aggregate suspension compositions and methods for differentiation thereof |
| AU2009313870B2 (en) | 2008-11-14 | 2013-07-11 | Viacyte, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
| WO2010059775A1 (en) | 2008-11-20 | 2010-05-27 | Centocor Ortho Biotech Inc. | Pluripotent stem cell culture on micro-carriers |
| US20110229441A1 (en) | 2008-12-05 | 2011-09-22 | Association Francaise Contre Les Myopathies | Method and Medium for Neural Differentiation of Pluripotent Cells |
| AU2010276440B2 (en) | 2009-07-20 | 2014-07-03 | Janssen Biotech Inc. | Differentiation of human embryonic stem cells |
| AR077766A1 (es) | 2009-07-20 | 2011-09-21 | Janssen Biotech Inc | Diferenciacion de celulas madre embrionarias humanas |
| RU2579278C2 (ru) | 2009-07-20 | 2016-04-10 | Янссен Байотек, Инк. | Популяция панкреатических эндокринных клеток-предшественников для снижения концентрации глюкозы в крови и способ дифференцировки панкреатических эндодермальных клеток |
| CN102597218B (zh) | 2009-08-12 | 2017-10-27 | 国立大学法人京都大学 | 用于诱导多能干细胞分化成神经前体细胞的方法 |
| EP2494035B1 (en) | 2009-10-29 | 2018-02-28 | Janssen Biotech, Inc. | Pluripotent stem cells |
| ES2932664T3 (es) | 2009-11-12 | 2023-01-23 | Technion Res & Dev Foundation | Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en estado no diferenciado |
| FI20096288A0 (fi) | 2009-12-04 | 2009-12-04 | Kristiina Rajala | Formulations and methods for culturing stem cells |
| RU2664864C1 (ru) | 2009-12-23 | 2018-08-23 | Янссен Байотек, Инк. | Способы увеличения экспрессии ngn3 и nkx6.1 в эндокринных клетках поджелудочной железы |
| JP6392496B2 (ja) | 2009-12-23 | 2018-09-19 | ヤンセン バイオテツク，インコーポレーテツド | ヒト胚性幹細胞の分化 |
| JP5762979B2 (ja) | 2009-12-29 | 2015-08-12 | 武田薬品工業株式会社 | 膵ホルモン産生細胞の製造法 |
| TR201000243A2 (tr) | 2010-01-13 | 2010-06-21 | Akdeni̇z Ahmet | Mile açılan kama kanalını ölçmeye ve kontrol etmeye yarayan ölçüm cihazı |
| EP2532741B1 (en) | 2010-02-03 | 2018-04-04 | Tetsuya Ishikawa | Induced hepatic stem cell and process for production thereof, and applications of the cell |
| SG183535A1 (en) * | 2010-03-01 | 2012-10-30 | Janssen Biotech Inc | Methods for purifying cells derived from pluripotent stem cells |
| WO2011108993A1 (en) | 2010-03-02 | 2011-09-09 | National University Of Singapore | Culture additives to boost stem cell proliferation and differentiation response |
| EP2553086B1 (en) | 2010-03-31 | 2017-04-19 | The Scripps Research Institute | Reprogramming cells |
| US9234170B2 (en) | 2010-04-25 | 2016-01-12 | Mount Sinai School Of Medicine | Generation of anterior foregut endoderm from pluripotent cells |
| CN107338217B (zh) * | 2010-05-12 | 2021-02-09 | 詹森生物科技公司 | 人胚胎干细胞的分化 |
| WO2011158960A1 (en) | 2010-06-15 | 2011-12-22 | Kyoto University | Method for selecting human induced pluripotent stem cells |
| WO2011160066A1 (en) | 2010-06-17 | 2011-12-22 | Regents Of The University Of Minnesota | Production of insulin producing cells |
| SG187699A1 (en) | 2010-08-05 | 2013-03-28 | Wisconsin Alumni Res Found | Simplified basic media for human pluripotent cell culture |
| NZ607608A (en) | 2010-08-09 | 2014-03-28 | Takeda Pharmaceuticals Co | Method of producing pancreatic hormone-producing cells |
| MX355077B (es) | 2010-08-31 | 2018-04-03 | Janssen Biotech Inc | Diferenciacion de celulas madre embrionarias humanas. |
| PL2611907T3 (pl) | 2010-08-31 | 2016-11-30 | Różnicowanie pluripotencjalnych komórek macierzystych | |
| MY177150A (en) | 2011-02-28 | 2020-09-08 | Stempeutics Res Malaysia Sdn Bhd | Isolation and expansion of adult stem cells, their therapeutic composition and uses thereof |
| WO2013055834A2 (en) | 2011-10-11 | 2013-04-18 | The New York Stem Cell Foundation | Er stress relievers in beta cell protection |
| US8951798B2 (en) | 2011-10-13 | 2015-02-10 | Wisconsin Alumni Research Foundation | Generation of cardiomyocytes from human pluripotent stem cells |
| US9670463B2 (en) | 2011-10-14 | 2017-06-06 | Children's Medical Center Corporation | Inhibition and enhancement of reprogramming by chromatin modifying enzymes |
| SG11201403473QA (en) * | 2011-12-22 | 2014-10-30 | Janssen Biotech Inc | Differentiation of human embryonic stem cells into single hormonal insulin positive cells |
| WO2013095593A1 (en) | 2011-12-22 | 2013-06-27 | Intel Corporation | Always-available embedded theft reaction subsystem |
| US10519422B2 (en) | 2012-02-29 | 2019-12-31 | Riken | Method of producing human retinal pigment epithelial cells |
| CA2875786C (en) | 2012-06-08 | 2022-12-06 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into pancreatic endocrine cells |
| WO2014033322A1 (en) | 2012-09-03 | 2014-03-06 | Novo Nordisk A/S | Generation of pancreatic endoderm from pluripotent stem cells using small molecules |
| US10138465B2 (en) | 2012-12-31 | 2018-11-27 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into pancreatic endocrine cells using HB9 regulators |
| DK2938724T3 (da) | 2012-12-31 | 2020-12-14 | Janssen Biotech Inc | Dyrkning af humane embryonale stamceller ved luft-væskegrænsefladen til differentiering til endokrine pankreasceller |
| WO2014127164A1 (en) | 2013-02-14 | 2014-08-21 | Allergan, Inc. | Substituted dihydropyrazoles as sphingosine receptor modulators |
| US8859286B2 (en) | 2013-03-14 | 2014-10-14 | Viacyte, Inc. | In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells |
| SG10201708332WA (en) | 2013-03-15 | 2017-11-29 | Jackson Lab | Isolation of non-embryonic stem cells and uses thereof |
| SG10201710218RA (en) | 2013-06-11 | 2018-01-30 | Harvard College | Sc-beta cells and compositions and methods for generating the same |
| ES2967942T3 (es) | 2016-02-24 | 2024-05-06 | Novo Nordisk As | Generación de células beta funcionales a partir de progenitoras endocrinas derivadas de células madre pluripotentes humanas |
-
2012
- 2012-12-07 SG SG11201403473QA patent/SG11201403473QA/en unknown
- 2012-12-07 BR BR112014015417A patent/BR112014015417A8/pt not_active Application Discontinuation
- 2012-12-07 RU RU2014130042A patent/RU2668798C2/ru active
- 2012-12-07 EP EP12860751.2A patent/EP2794857A4/en active Pending
- 2012-12-07 AU AU2012355698A patent/AU2012355698B2/en active Active
- 2012-12-07 WO PCT/US2012/068439 patent/WO2013095953A1/en active Application Filing
- 2012-12-07 SG SG10201608914WA patent/SG10201608914WA/en unknown
- 2012-12-07 CN CN201280070187.1A patent/CN105143446B/zh active Active
- 2012-12-07 KR KR1020147020267A patent/KR102090751B1/ko active IP Right Grant
- 2012-12-07 JP JP2014549094A patent/JP6441080B2/ja active Active
- 2012-12-07 US US13/708,369 patent/US9388386B2/en active Active
- 2012-12-07 KR KR1020207007316A patent/KR102203056B1/ko active IP Right Grant
- 2012-12-07 RU RU2018132199A patent/RU2705001C2/ru active
- 2012-12-07 CA CA2860107A patent/CA2860107C/en active Active
- 2012-12-07 MX MX2014007744A patent/MX2014007744A/es unknown
- 2012-12-21 AR ARP120104934A patent/AR089426A1/es unknown
-
2014
- 2014-06-20 PH PH12014501429A patent/PH12014501429A1/en unknown
-
2015
- 2015-04-27 HK HK15104026.3A patent/HK1203552A1/xx unknown
- 2015-08-20 US US14/831,115 patent/US10358628B2/en active Active
-
2018
- 2018-11-21 JP JP2018218327A patent/JP6851358B2/ja active Active
-
2019
- 2019-02-25 AU AU2019201293A patent/AU2019201293B2/en active Active
- 2019-06-07 US US16/435,428 patent/US11377640B2/en active Active
-
2020
- 2020-12-18 JP JP2020210764A patent/JP7191925B2/ja active Active
-
2021
- 2021-08-23 AU AU2021221411A patent/AU2021221411B2/en active Active
-
2022
- 2022-05-20 US US17/749,735 patent/US20220275340A1/en active Pending
- 2022-12-06 JP JP2022194566A patent/JP2023025204A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018132199A (ru) | Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки | |
| RU2015131838A (ru) | Дифференцировка эмбриональных стволовых клеток человека в панкреатические эндокринные клетки с помощью регуляторов нв9 | |
| AR094347A1 (es) | Cultivo de células madre embrionarias humanas en la interfase aire-líquido para la diferenciación en células endocrinas pancreáticas | |
| RU2017125728A (ru) | Культивирование плюрипотентных стволовых клеток в суспензии | |
| RU2017102194A (ru) | Дифференцировка человеческих эмбриональных стволовых клеток | |
| RU2018108851A (ru) | Дифференцировка эмбриональных стволовых клеток человека в панкреатические эндокринные клетки | |
| RU2012105924A (ru) | Дифференцировка эмбриональных стволовых клеток человека | |
| AR081040A1 (es) | Diferenciacion de celulas madre embrionarias humanas | |
| RU2010107224A (ru) | Дифференцировка человеческих эмбриональных стволовых клеток | |
| AR082820A1 (es) | Diferenciacion de celulas madre embrionarias humanas | |
| RU2019101200A (ru) | Генерация функциональных бета-клеток, полученных из человеческой плюрипотентной стволовой клетки, демонстрирующих реакцию в виде глюкозозависимого митохондриального дыхания и двухфазной секреции инсулина | |
| RU2012105923A (ru) | Дифференцировка эмбриональных стволовых клеток человека | |
| EA201101111A1 (ru) | Алкиламинозамещенные дицианопиридины и их пролекарства в виде сложных эфиров с аминокислотами | |
| JP2016503654A5 (ru) | ||
| ES2721440T3 (es) | Nuevo método para inducir células precursoras neurales productoras de dopamina | |
| RU2014149185A (ru) | Дифференцирование эмбриональных стволовых клеток человека в панкреатическую энтодерму | |
| JP2012507289A5 (ru) | ||
| MX2010014101A (es) | Aparato y metodos para controlar el desarrollo celular. | |
| EA201101568A1 (ru) | Лечение ex vivo иммунологических нарушений с помощью ингибиторов pkc-teta | |
| CN108060120A (zh) | 用于分化的细胞重编程的小分子化合物组合、试剂盒及应用 | |
| CN108060123B (zh) | 一种用于体细胞去分化的靶点调控系统、试剂盒及应用 | |
| Rodprasert et al. | Tailored generation of insulin producing cells from canine mesenchymal stem cells derived from bone marrow and adipose tissue | |
| EP2547761A4 (en) | METHOD FOR THE CULTURE OF PANCREATIC ISLAND TISSUE TYPES BY A TISSUE COMPLEX CONSISTING OF NON-ENDOCRINE EPITHELIAL CELLS DERIVED FROM PANCREAS AND ENDOTHELIAL VASCULAR CELLS | |
| CN108060126A (zh) | 一种诱导分化的细胞制备间充质干细胞的方法及调控靶点的组合 | |
| Yuan et al. | Role of FAK-ERK1/2 signaling pathway in proliferation of rat bone-marrow mesenchymal stem cells stimulated by cyclic stretching |